H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT

Adlai Nortye Ltd. (NASDAQ:ANL) is one of the best performing small cap stocks so far in 2026. On April 20, H.C. Wainwright lifted the price target on Adlai Nortye Ltd. (NASDAQ:ANL) to $20 from $16 while maintaining a Buy rating on the shares. The firm told investors in a research note that the company’s lead asset, AN9025, demonstrates “potential best-in-class potency”, positioning it as a differentiated next-generation small molecule pan-RAS(ON) inhibitor.

In a separate development, Adlai Nortye Ltd. (NASDAQ:ANL) announced on April 16 that it has entered into a securities purchase agreement for a private investment in public equity financing that is anticipated to result in gross proceeds of approximately $150.0 million. This is before deducting placement agent fees and other private placement expenses.

Management reported that the oversubscribed transaction includes participation from both new and existing institutional investors, with new investors including Soleus Capital, Perceptive Advisors, ADAR1 Capital Management, MPM BioImpact, Octagon Capital, Eventide Asset Management, Kalehua Capital, and DAFNA Capital Management, and more. Adlai Nortye Ltd. (NASDAQ:ANL) also reported additional participation from existing investors, including Cormorant Asset Management, Columbia Threadneedle Investments, Balyasny Asset Management, Casdin Capital, Squadron Capital Management, and Superstring Capital Management, etc.

Adlai Nortye Ltd. (NASDAQ:ANL) is a clinical-stage biopharmaceutical company involved in the development of cancer therapies for patients with various stages of tumors. The company offers AN0025, which is a clinical-stage, potential EP4 antagonist designed to modulate the tumor microenvironment.

While we acknowledge the potential of ANL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.